These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2924984)

  • 21. Response of the clinically uninvolved skin of psoriatic patients to tape stripping during acitretin treatment.
    Gerritsen MJ; van Pelt JP; van de Kerkhof PC
    Acta Derm Venereol; 1996 Jan; 76(1):6-9. PubMed ID: 8721480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An altered response by psoriatic keratinocytes to gamma interferon.
    Baker BS; Powles AV; Valdimarsson H; Fry L
    Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis.
    Castelijns FA; Gerritsen MJ; van Vlijmen-Willems IM; van Erp PE; van de Kerkhof PC
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):901-9. PubMed ID: 10365920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interferon-gamma receptors in normal and psoriatic skin.
    Scheynius A; Fransson J; Johansson C; Hammar H; Baker B; Fry L; Valdimarsson H
    J Invest Dermatol; 1992 Feb; 98(2):255-8. PubMed ID: 1531061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies for epidermal population analysis.
    Bauer FW; Boezeman JB; van Engelen L; de Grood RM; Ramaekers FC
    J Invest Dermatol; 1986 Jul; 87(1):72-5. PubMed ID: 2425007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.
    de Mare S; Van Erp PE; van de Kerkhof PC
    J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of clinically normal skin in early eruptive guttate psoriasis. A light- and electron-microscopic study.
    Brody I
    J Cutan Pathol; 1978 Oct; 5(5):219-33. PubMed ID: 730863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
    Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
    Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.
    Kleinpenning MM; Smits T; Ewalds E; van Erp PE; van de Kerkhof PC; Gerritsen MJ
    Br J Dermatol; 2006 Sep; 155(3):539-45. PubMed ID: 16911278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch.
    Taneda K; Tominaga M; Negi O; Tengara S; Kamo A; Ogawa H; Takamori K
    Br J Dermatol; 2011 Aug; 165(2):277-84. PubMed ID: 21457210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc gamma receptors on keratinocytes in psoriasis.
    Livden JK
    Arch Dermatol Res; 1988; 280(1):12-7. PubMed ID: 2451478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stripping of the stratum corneum in patients with psoriasis: production of prepinpoint papules and psoriatic lesions.
    Jablonska S; Chowaniec O; Beutner EH; Maciejowska E; Jarzabek-Chorzelska M; Rzesa G
    Arch Dermatol; 1982 Sep; 118(9):652-7. PubMed ID: 7114867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.